LivaNova PLC (LIVN) P/E Ratio History
Historical price-to-earnings valuation from 2017 to 2026
Loading P/E history...
LIVN Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 8, 2026, LivaNova PLC (LIVN) trades at a price-to-earnings ratio of -15.9x, with a stock price of $70.92 and trailing twelve-month earnings per share of $1.92.
The current P/E is 107% below its 5-year average of 223.2x. Over the past five years, LIVN's P/E has ranged from a low of 32.4x to a high of 1034.8x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.3x, LIVN trades at a 171% discount to its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 177.5x.
Relative to the broader market, LIVN trades at a notable discount to the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our LIVN DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
LIVN P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $2B | 6.9Lowest | 0.67 | +817%Best | |
| $100B | 21.6 | - | +31% | |
| $151B | 11.4 | 0.38Best | +134% | |
| $84B | 29.2 | - | +55% | |
| $113B | 35.0 | 2.36 | +8% | |
| $222M | 31.2 | 2.43 | +48% | |
| $17B | 30.5 | - | -25% | |
| $161B | 57.6 | 2.65 | +23% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
LIVN Historical P/E Data (2017–2026)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2026 Q1 | $63.56 | $1.96 | 32.4x | -85% | |
| FY2024 Q4 | $46.31 | $1.14 | 40.6x | -82% | |
| FY2024 Q3 | Mon Sep 30 2024 00:00:00 GM | $52.54 | $0.42 | 125.1x | -44% |
| FY2023 Q4 | Sun Dec 31 2023 00:00:00 GM | $51.74 | $0.32 | 161.7x | -28% |
| FY2023 Q3 | Sat Sep 30 2023 00:00:00 GM | $52.88 | $0.05 | 1034.8x | +364% |
| FY2017 Q3 | Sat Sep 30 2017 00:00:00 GM | $70.06 | $1.17 | 59.9x | -73% |
| FY2017 Q2 | Fri Jun 30 2017 00:00:00 GM | $61.21 | $0.57 | 107.8x | -52% |
Average P/E for displayed period: 223.2x
See LIVN's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs LIVN Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare LIVN vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonLIVN — Frequently Asked Questions
Quick answers to the most common questions about buying LIVN stock.
Is LIVN stock overvalued or undervalued?
LIVN trades at -15.9x P/E, below its 5-year average of 223.2x. At the N/A percentile of historical range, the stock is priced at a discount to its own history.
How does LIVN's valuation compare to peers?
LivaNova PLC P/E of -15.9x compares to sector median of 22.3x. The discount suggests lower growth expectations or higher risk.
What is LIVN's PEG ratio?
LIVN PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2017-2026.